E11.355
Type 2 diabetes mellitus with stable proliferative diabetic retinopathy
Clinical Classification Guidelines
Medical Intelligence & Overview
Type 2 diabetes mellitus is a chronic condition that affects how your body processes blood sugar (glucose). When diabetes is not well-controlled, it can lead to complications such as diabetic retinopathy, which affects the eyes. Specifically, the code E11.355 describes a case where a person with type 2 diabetes has developed proliferative diabetic retinopathy that has stabilized over time. This condition requires ongoing management to prevent further vision loss and maintain eye health.
Causes & Symptoms
Clinical Causes: Long-standing high blood sugar levels can damage the tiny blood vessels in the retina. Poor control of blood glucose levels over time increases the risk of diabetic retinopathy. High blood pressure and high cholesterol can exacerbate damage to retinal vessels. Duration of diabetes is a significant factor; the longer a person has diabetes, the higher the risk. Genetic factors may influence susceptibility to diabetic eye complications.
Key Symptoms: Gradually worsening vision or blurred vision Seeing floaters or spots in the visual field Difficulty perceiving colors or contrast Possible episodes of sudden vision loss, which may improve temporarily No symptoms in early stages, emphasizing the importance of regular eye screenings
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves an eye examination by an ophthalmologist, including procedures such as dilated retinal exams and imaging tests like fundus photography or optical coherence tomography (OCT). These tests help assess the severity of diabetic retinopathy and monitor its progression or stabilization. Regular eye exams are vital for early detection and management.
Treatment Protocols: While proliferative diabetic retinopathy can be stabilized through various treatments, it often requires ongoing management to prevent progression. Common approaches include: - Laser therapy (photocoagulation) to seal abnormal blood vessels and prevent further bleeding - Intravitreal injections of medications like anti-VEGF agents to reduce new blood vessel growth - Tight control of blood sugar, blood pressure, and cholesterol levels to reduce the risk of further issues - Regular monitoring to assess changes and respond swiftly to complications In cases where the condition remains stable, continued observation and management are key to preserving vision and preventing vision loss.
Clinical Advice & FAQs
Billing Guidance
Is E11.355 a billable ICD-10 code?
Yes, E11.355 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E11.355?
Clinical documentation must specify the nature of Type 2 diabetes mellitus with stable proliferative diabetic retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
